Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) updated its FY18 earnings guidance on Thursday. The company provided EPS guidance of $2.41-2.47 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.51. Sabra Healthcare REIT also updated its FY17 guidance to $2.29-2.33 EPS.

A number of research analysts recently commented on the company. Mizuho cut Sabra Healthcare REIT from a neutral rating to an underperform rating and decreased their price objective for the company from $25.00 to $23.00 in a report on Monday, July 10th. BidaskClub upgraded Sabra Healthcare REIT from a sell rating to a hold rating in a report on Tuesday, June 20th. Zacks Investment Research cut Sabra Healthcare REIT from a buy rating to a hold rating in a report on Wednesday, August 30th. Stifel Nicolaus reiterated a hold rating and issued a $26.00 price objective on shares of Sabra Healthcare REIT in a report on Friday, July 28th. Finally, Jefferies Group LLC upgraded Sabra Healthcare REIT from a hold rating to a buy rating and set a $25.00 price objective on the stock in a report on Tuesday, August 15th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of Hold and a consensus price target of $25.29.

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) traded down 1.15% on Thursday, reaching $22.34. The company’s stock had a trading volume of 1,482,744 shares. The firm has a 50 day moving average price of $22.43 and a 200 day moving average price of $24.81. Sabra Healthcare REIT, Inc. has a 52 week low of $19.30 and a 52 week high of $29.10. The stock has a market capitalization of $1.46 billion, a P/E ratio of 18.80 and a beta of 0.89.

The firm also recently announced a quarterly dividend, which was paid on Friday, August 18th. Investors of record on Wednesday, August 16th were issued a dividend of $0.3599 per share. The ex-dividend date was Monday, August 14th. This represents a $1.44 annualized dividend and a dividend yield of 6.44%. Sabra Healthcare REIT’s payout ratio is 122.03%.

ILLEGAL ACTIVITY WARNING: This story was first reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/09/07/sabra-healthcare-reit-inc-sbra-issues-fy18-earnings-guidance.html.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Earnings History and Estimates for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.